Novartis, Myriad May Get Shield for Diagnostic Tests After High Court Case
Novartis, Myriad May Get Shield for Diagnostic Tests After High Court Case
Myriad Genetics Inc. , Genomic Health Inc. and the rest of the burgeoning industry for personalized medicine stand to gain from yesterday’s landmark U.S. Supreme Court decision on patenting business methods.
Read more on Bloomberg